Polaris Market Research today announced findings from its latest report, projecting the global artificial intelligence in precision medicine market to grow from USD 2.53 billion in 2025 to USD 38.88 billion by 2034, at a CAGR of 35.5%. The report profiles 15 leading companies across three market segments and covers the forecast period from 2026 through 2034. AI in precision medicine integrates machine learning and deep learning with genomic, clinical, and lifestyle data to enable more accurate diagnosis, personalized treatment planning, and faster drug development.

Analyst Commentary on Artificial Intelligence in Precision Medicine Market Growth

“Advancements in AI algorithms and the growing volume of genomic and clinical data are transforming how treatments are personalized,” said a Polaris Market Research spokesperson. “Buyers evaluating market entry should watch the oncology and neurology segments, where AI-driven diagnostics and treatment prediction tools are advancing fastest.”

Artificial Intelligence in Precision Medicine Market Statistics at a Glance

• 2025 Market Size: USD 2.53 Billion
• 2026 Market Estimate: USD 3.41 Billion
• 2034 Projected Size: USD 38.88 Billion
• CAGR (2026-2034): 35.5%
• Largest Region (2025): North America, 43.3% share

Key Growth Drivers, Major Companies and Segments Covered

Growth Drivers: rapid advancements in AI algorithms, the growing availability of healthcare data from genomics, electronic health records, and wearables, and rising demand for personalized medicine are the primary forces behind the market's expansion, alongside increased use of AI in drug discovery and medical imaging. Genomic data generated globally is expected to double every two years, per a study published in Nature Biotechnology, underscoring the scale of data now available for AI-driven analysis. In February 2026, Tempus AI launched its HRD-RNA algorithm to identify cancer patients likely to benefit from PARP inhibitors and platinum therapies.

Major Companies Covered: IBM Corporation, Microsoft Corporation, Google Health, NVIDIA Corporation, and Tempus Labs, among 15 total companies profiled in the report.

Segments Covered: By Technology (deep learning, querying method, natural language processing, context-aware processing), By Component (hardware, software, services), By Therapeutic Application (oncology, cardiology, neurology, respiratory), By Region.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 :

https://www.polarismarketresearch.com/industry-analysis/artificial-intelligence-in-precision-medicine-market 

Recent Developments in the Artificial Intelligence in Precision Medicine Market

• May 2026: Myriad Genetics launched Prolaris + AI, combining genomics and digital pathology AI to improve prostate cancer risk assessment and treatment decisions.
• January 2026: Natera partnered with NVIDIA to develop multimodal AI foundation models supporting advanced diagnostics and personalized treatment development.

Segment Highlights: Deep Learning and Software Lead, Neurology Fastest-Growing

Deep learning accounted for the largest technology share at 39.5% in 2025, owing to its ability to process large volumes of genomic and imaging data for disease diagnosis, predictive modeling, and drug discovery. By component, software captured the highest share at 54.3% in 2025, driven by growing adoption of AI-powered analytics, predictive modeling, and personalized treatment platforms, while services is the fastest-growing category as providers seek AI consultancy, integration, and support. By therapeutic application, oncology dominated with a 42.6% share in 2025 on the strength of AI-based cancer detection and genetic mutation analysis, while neurology is projected to post the fastest CAGR at 36.9% through 2034 as AI tools advance early diagnosis of Alzheimer's, Parkinson's, and related disorders.

Regional Snapshot: North America Leads, Asia Pacific Fastest-Growing

North America led with a 43.3% share in 2025, supported by advanced healthcare infrastructure, strong AI investment, and a dense presence of key market players, while Asia Pacific is projected to register the fastest CAGR of 37.4% through 2034 on the back of rising healthcare digitalization and expanding AI investment in China, Japan, and India. Europe continues to see steady growth, led by the UK, Germany, and France, supported by government initiatives and evolving digital health regulatory frameworks. Key players including IBM, Microsoft, Google Health, and NVIDIA compete alongside specialized firms such as Tempus Labs and PathAI, with partnerships between AI developers and healthcare providers becoming increasingly common to expand access to personalized medicine.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching the Artificial Intelligence in Precision Medicine Market, the underlying report benchmarks market share, company positioning, and segment-level forecasts across technology, component, therapeutic application, and region to support sourcing, partnership, and investment decisions through 2034. The 118-page report, authored by Shreyas Shirsat and reviewed by Prajakta Bengale, also details historical data from 2021 through 2024 to help buyers contextualize the forecast and identify priority therapeutic areas.

More Trending Latest Reports By Polaris Market Research:

Expanded Polystyrene Market

Underwater Warfare Market

Smoke Evacuation Systems Market

Protein A, G, and L Resins Market

Underwater Warfare Market

Agricultural Robots Market

Window Lift Motors Market

The Appetizing World of Food & Beverage Non-Fungible Token (NFT) Market

Recycled Plastics Market